Voya Investment Management LLC Denali Therapeutics Inc. Transaction History

Voya Investment Management LLC

$79.9 Billion
Q3 2024

A detailed history of Voya Investment Management LLC transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Voya Investment Management LLC holds 57,804 shares of DNLI stock, worth $1.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

57,804

Previous 58,780 1.66%

Holding current value

$1.4 Million

Previous $1.36 Million 23.39%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$20.96 - $31.05 $20,456 - $30,304	-976 Reduced 1.66%	57,804 $1.68 Million
Q2 2024 Aug 14, 2024	SELL	$14.96 - $23.22 $2.28 Million - $3.54 Million	-152,361 Reduced 72.16%	58,780 $1.36 Million
Q1 2024 May 15, 2024	SELL	$15.83 - $23.35 $1 Million - $1.48 Million	-63,466 Reduced 23.11%	211,141 $4.33 Million
Q4 2023 Feb 14, 2024	BUY	$16.2 - $23.18 $309,857 - $443,363	19,127 Added 7.49%	274,607 $5.89 Million
Q3 2023 Nov 14, 2023	BUY	$20.63 - $30.17 $22,878 - $33,458	1,109 Added 0.44%	255,480 $5.27 Million
Q2 2023 Aug 14, 2023	BUY	$23.37 - $32.96 $1.62 Million - $2.29 Million	69,521 Added 37.61%	254,371 $7.51 Million
Q1 2023 May 15, 2023	BUY	$21.91 - $32.67 $478,821 - $713,970	21,854 Added 13.41%	184,850 $4.26 Million
Q4 2022 Feb 14, 2023	BUY	$26.28 - $33.92 $106,539 - $137,511	4,054 Added 2.55%	162,996 $4.53 Million
Q3 2022 Mar 03, 2023	SELL	$25.97 - $38.53 $105,282 - $156,200	-4,054 Reduced 2.49%	158,942 $4.88 Million
Q3 2022 Nov 14, 2022	SELL	$25.97 - $38.53 $1.87 Million - $2.77 Million	-71,888 Reduced 31.14%	158,942 $4.88 Million
Q2 2022 Aug 15, 2022	BUY	$20.88 - $35.19 $2.08 Million - $3.51 Million	99,848 Added 76.23%	230,830 $6.79 Million
Q1 2022 May 16, 2022	BUY	$29.0 - $47.27 $2.78 Million - $4.53 Million	95,909 Added 273.46%	130,982 $4.22 Million
Q4 2021 Feb 14, 2022	SELL	$42.59 - $55.02 $22,061 - $28,500	-518 Reduced 1.46%	35,073 $1.56 Million
Q3 2021 Nov 15, 2021	SELL	$48.48 - $78.23 $8,435 - $13,612	-174 Reduced 0.49%	35,591 $1.8 Million
Q2 2021 Aug 16, 2021	BUY	$50.3 - $78.44 $412,057 - $642,580	8,192 Added 29.71%	35,765 $2.81 Million
Q1 2021 May 17, 2021	BUY	$53.8 - $81.53 $11,997 - $18,181	223 Added 0.82%	27,573 $1.57 Million
Q4 2020 Feb 16, 2021	BUY	$36.89 - $93.56 $201,714 - $511,586	5,468 Added 24.99%	27,350 $2.29 Million
Q2 2020 Aug 14, 2020	SELL	$16.01 - $28.82 $51,280 - $92,310	-3,203 Reduced 12.77%	21,882 $529,000
Q1 2020 May 15, 2020	BUY	$14.2 - $27.98 $25,389 - $50,028	1,788 Added 7.67%	25,085 $439,000
Q4 2019 Feb 14, 2020	BUY	$14.4 - $19.99 $55,684 - $77,301	3,867 Added 19.9%	23,297 $406,000
Q2 2019 Aug 14, 2019	BUY	$18.5 - $28.14 $15,336 - $23,328	829 Added 4.46%	19,430 $403,000
Q4 2018 Feb 14, 2019	BUY	$13.88 - $21.75 $25,025 - $39,215	1,803 Added 10.73%	18,601 $384,000
Q3 2018 Nov 14, 2018	BUY	$12.46 - $21.74 $209,303 - $365,188	16,798 New	16,798 $365,000

Others Institutions Holding DNLI

# of Institutions

228

Shares Held

120M

Call Options Held

60.6K

Put Options Held

48.4K

View Full List

About Denali Therapeutics Inc.

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $3.25B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

More about DNLI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.

Account

Voya Investment Management LLC Denali Therapeutics Inc. Transaction History